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Abstract
 
Background: Once considered as the main public health problem in developed countries, obesity has 
become a major problem throughout the world and developing countries, like Iran, are joining the global 
obesity pandemic. We determined the prevalence of overweight, obesity, and hypertension in a large 
cohort of Iranians and compared age-adjusted rates with the rates in the US. 
Methods: Golestan Cohort Study is a population-based study of 8,998 men and women, aged 35-81 years, 
from urban and rural areas. Anthropometric parameters were measured by interviewers. Prevalence rates 
were directly adjusted to the 2000 United States standard population. 
Results: The age-adjusted prevalence rates of overweight (BMI ≥ 25 kg/m2) and obesity (BMI ≥ 30 kg/m2) 
in this Iranian population were 62.2% and 28.0%, respectively.  Both overweight and obesity were more 
common in women than men. Age-adjusted prevalence of overweight was significantly higher in Iranian 
women compared to the American women (68.6% vs. 61.6%), while the age-adjusted prevalence of obesity 
is closer in these two populations (34.9% vs. 33.2%). Iranian men—compared to American men—had 
significantly lower age-adjusted prevalence of overweight (53.7% vs. 68.8%) and obesity (16.2% vs. 27.5%). 
Age-adjusted prevalence of hypertension was higher in Iranian women than American women (35.7% vs. 
30.5%). Diabetes mellitus was reported in 6.2% of participants. Mean waist-to-hip ratio (WHR) among 
women was 0.96. Smoking rates in men and women were 33.2% and 2.2%, respectively. 
Conclusion: The prevalence of obesity, overweight, and hypertension in  Iran is as high as the US.  
However, Iranian women are more obese than American women and Iranian men are less obese than their 
American counterparts. This discrepancy might be due to the low rate of smoking among Iranian women. 
Iranian women have higher mean WHR than what WHO has defined in 19 other populations. Page 1 of 9 
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Background 
Listing medical and health-related issues in the Middle 
East, the first things that come to one's minds might be 
problems like infectious diseases that are more common 
in developing countries. However, by merely focusing on 
specific types of endemic diseases in the region, we under­
mine significant problems like obesity and metabolic syn­
drome that might have equal or even greater impact on 
the health of people in these countries. Although these 
health issues are more discussed in developed countries, 
we should notice that most Middle Eastern countries are 
joining the global obesity pandemic and the problem 
becomes more significant when we consider the trend in 
developing countries toward the Western lifestyles. This 
westernization can potentially put the population of these 
countries at higher risk of obesity and metabolic syn­
drome than western countries. It is suggested that fetal 
growth and maternal nutrition have crucial effects on epi­
genetic programming of obesity, metabolic syndrome, 
diabetes, and hypertension [1-3] and in these countries 
we are dealing with a generation born in more traditional 
environment–and therefore more susceptible to obesity 
and insulin resistance–who is exposed to high-calorie 
foods and sedentary lifestyle. Failure of the scientific com­
munity in recognizing the problem will result in a Middle 
East with an alarming situation like what we see in Pima 
Indians in the US [4,5] or adults with prenatal exposure to 
Dutch famine in Europe [6,7]. As Horton has highlighted, 
we have an unusual opportunity to act in order to prevent 
the needless deaths of millions by focusing on risk factors 
of chronic diseases in low-income countries [8]. 
Obesity is a major medical and public health problem 
world-wide and by consequences like type 2 diabetes mel­
litus and insulin resistance ultimately causes several 
health conditions like cardiovascular and cerebrovascular 
diseases, certain types of cancers, hypertension, gallblad­
der disease, nonalcoholic steatohepatitis, and obesity­
hypoventilation syndrome. In addition to overall obesity, 
abdominal obesity is considered as independent predictor 
of several risk factors and morbidity [9,10]. 
This paper estimates the prevalence of overweight, obes­
ity, and abdominal obesity in Iran using the da large 
cohort study, the Golestan Cohort Study. The age-
adjusted and age-specific prevalence rates will be com­
pared to the rates in the United States. Considering the 
association of obesity with metabolic syndrome, we esti­
mate the prevalence of hypertension and diabetes melli­
tus–two other criteria for metabolic syndrome and two 
independent risk factors for many comorbid conditions– 
in addition to obesity. 
Methods 
Study population 
This study analyzes the data from the Golestan Cohort 
Study, a large study that is conducted in North-East of 
Iran. The study is an ongoing population-based cohort 
with the main objective of investigating the incidence of 
esophageal cancer and the associated risk factors. For this 
analysis, we included data from 8,999 participants 
recruited between 2002 and 2005. The study is sponsored 
by Digestive Diseases Research Center (DDRC) at Tehran 
University of Medical Sciences (Tehran, Iran), Interna­
tional Agency for Research on Cancer (IARC; Lyon, 
France), and Golestan University of Medical Sciences, 
Iran. One participant was excluded from the analysis 
because his height was missing. The study adhered to the 
Declaration of Helsinki [11] and was approved by the 
Institutional Review Board of the DDRC. 
Residents were selected by household sampling and con­
tacted at their home by expert local health professionals, 
who thoroughly explained them the purpose and proce­
dure of the study. Individuals were invited to participate 
by attending the health service centers located in their area 
or the Golestan Cohort Study Center for interview. More 
than 75% of rural subjects and 62% of urban subjects who 
were invited to the study participated. Interviewers were 
local physicians and, in the case of dietary interviews, 
nutritionists who were trained for this purpose. Exclusion 
criteria were: (1) being a temporary resident; and (2) pre­
vious history of upper gastrointestinal cancer. 
Data collection 
Before interview, a written informed consent was 
obtained from all study participants. Detailed data con­
cerning alcohol consumption and smoking as well as 
type, duration, and estimated amount of drinking/smok­
ing were collected. Demographic and anthropometric 
data were collected on all participants. Weight (kg), height 
(cm), waist and hip circumferences (cm) were measured 
by interviewers and recorded with precision of one unit. 
The values for weight were rounded to the nearest 0.5 kg 
and height was rounded to the nearest 0.1 cm. Subjects 
were wearing light clothes. Three anthropometric indices 
that were analyzed in this study were body mass index 
(BMI), waist-to-hip ratio (WHR), and waist circumference 
(WC). BMI was calculated using the formula weight(kg)/ 
[height(m)]2 and WHR was defined as the ratio of waist 
circumference (WC) to hip circumference. BMI is recog­
nized as the measure of overall obesity. A BMI ≥ 25 kg/m2 
was defined as overweight and a BMI ≥ 30 kg/m2 was 
defined as obesity. Individuals with BMI<18.5 kg/m2 were 
considered as underweight. WHR and WC were used as 
measures of abdominal obesity. A WHR ≥ 0.95 in men 
and = 0.85 in women were considered as high WHR Page 2 of 9 
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Table 1: Demographic and anthropometric characteristics of the participants in Golestan Cohort Study, Iran. 
Demographic/Anthropometric Characteristics Men (N = 3,787) Women (N = 5,212) 
Age (years) 53.7 (53.4–54.0) 52.2 (52.0 – 52.5) 
Rural 41.7% 43.0% 
Smoking Current Use 33.2% 2.2% 
Ever Used 47.0% 2.6% 
Alcohol Consumption Current Use 7.2% 0.1% 
Ever Used 17.8% 0.1% 
BMI (kg/m2) 25.8 (25.6–26.1) 28.6 (28.3–28.8) 
BMI Categories Obesity (BMI = 30 kg/m2) 17.0% 36.7% 
Overweight (25 = BMI <30 kg/m2) 38.0% 33.1% 
Normal weight (18.5 = BMI<25 kg/ 40.3% 26.8% 
m2) 
Underweight (BMI <18.5 kg/m2) 4.8% 3.5% 
Waist Circumference (cm) 96.0 (95.6–96.4) 98.0(97.3–98.7) 
Waist-to-Hip Ratio 0.96 (0.95–0.96) 0.96(0.95–0.97) 
(abdominal obesity) [10]. Also, a WC>102 cm in men and 
>88 cm in women were considered as high WC [9]. 
Two recordings of systolic and diastolic blood pressures 
were obtained for each arm in sitting position. Hyperten­
sion was defined as any of these conditions: (1) average 
systolic blood pressure ≥ 140 mmHg; (2) average diastolic 
blood pressure ≥ 90 mmHg; (3) being known case of 
hypertension (diagnosed by a physician) or receiving 
medications for hypertension. 
Diabetes mellitus was defined by self-report. A question­
naire including questions about different mild, moderate, 
and strenuous physical activities were filled for all partici­
pants. Metabolic equivalent (MET) for various activities 
was calculated based on an updated Compendium of 
Physical Activities [12]. Data on calorie intake calculated 
from food-frequency questionnaire (FFQ) was available 
for 4,048 participants. Total daily calorie intake was calcu­
lated using a Food Processor© Nutrition Analysis Software 
(Elizabeth Stuart Hands and Associates (ESHA) Research, 
Salem, Oregon). 
Statistical analysis 
The data are presented as crude and adjusted prevalence 
rates, standard errors, and 95% confidence intervals 
(binomial exact confidence intervals). Prevalence rates 
have been directly adjusted to the 2000 United States 
standard population [13] using 5-year age groups. The 
main reason for this adjustment was to compare the 
results with the results of the Third National Health and 
Nutrition Examination Survey (NHANES III) in the 
United States [14]. Since the age range in our study popu­
lation was from 35 to 81 years, we considered one 81­
year-old and two 80-year-old participants in the age group 
75–79. 
Generalized linear regression model is used to estimate 
predictors of BMI. We used logistic regression to deter­
mine the association of binary outcomes with independ­
ent covariates. Model assumptions and robustness of our 
results to highly influential observations were checked 
(using regression diagnostics, dbetas, and dfits). Data on 
continuous variables are presented as mean ± standard 
deviation (SD). Prevalence rates are presented as percent 
and 95% confidence interval (CI). T test and chi-square 
test have been used to compare numeric and categorical 
variables, respectively. Data analyses were performed 
using Stata® statistical software (Version 8.0, Stata Inc., 
College Station, TX). 
Results 
Prevalence of obesity and overweight 
Excluding one individual whose height was missing from 
the analysis, the study population consisted of 8,998 par­
ticipants (3,786 men and 5,212 women) with mean ± SD 
age of 52.8 ± 9.4 years (range 35 to 81 years). Among 
these participants, 5,182 individuals (57.6%) were from 
urban population and 3,817 individuals (42.4%) were 
from rural area. Table 1 summarizes the general character­
istics of the study population. 
The overall prevalence of overweight (BMI ≥ 25 kg/m2) 
was 63.5% (95% CI: 62.5%–64.5%). The prevalence of 
overweight was slightly higher in younger age groups, but 
it was significantly reduced after 65 years old (p-value for 
trend < 0.01). The prevalence of overweight was signifi­
cantly (p-value < 0.01) higher in women than men 
(69.7% vs. 54.9%). 
The overall prevalence of obesity (BMI ≥ 30 kg/m2) was 
28.4% (95% CI: 27.4%–29.3%). The pattern of change in 
the prevalence of obesity across different age groups was Page 3 of 9 
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Age-specific prevalence of obesity and overweight among Iranian and American participants of the Golestan Cohort Study and Third National Health and Nutritio  Examinat on Survey (NHANES III), respectively
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Figure 1 
Age-specific prevalence of obesity and overweight among Iranian and American participants of the Golestan Cohort Study and 
Third National Health and Nutrition Examination Survey (NHANES III), respectively. Note: Error bars indicate 1.96*standard 
error. 
similar to the prevalence of overweight. Women had a sig­
nificantly higher prevalence of obesity compared to men 
(36.7% vs. 17.0%, p-value < 0.01). 
Table 2 compares the unadjusted and adjusted prevalence 
rates of obesity and overweight in this Iranian population 
to the rates in the United States. Adjustments have been 
performed in both populations to the 2000 US standard 
population using 5-year age groups. The adjusted preva­
lence rates of overweight and obesity in this Iranian pop­
ulation were 62.2% and 28.0%, respectively. These rates 
are very close to similar rates in the US population (65.1% 
and 30.4%, respectively). However, gender-specific rates 
demonstrate that the age-adjusted prevalence of over­
weight is significantly higher in Iranian women compared 
to the American women (68.6% vs. 61.6%), while the age-
adjusted prevalence of obesity is closer in these two pop­
ulations (34.9% vs. 33.2%). On the contrary, Iranian men 
have significantly lower age-adjusted prevalence of over­
weight (53.7% vs. 68.8%) and obesity (16.2% vs. 27.5%). 
Figure 1 illustrates the gender- and age-specific prevalence 
rates of obesity and overweight in these two populations. 
As illustrated in this figure, Iranian men have higher prev­
alence of both obesity and overweight in all age-groups 
shown in this figure, while Iranian women have higher 
prevalence of obesity and overweight in lower age-groups, 
which constitute considerable proportions of the popula­
tion (about 62% of the US population above 35 years old 
in 2000 were in the age-groups 35 to 55, where Iranian 
women have a significantly higher prevalence of obesity). 
In the logistic regression model for both obesity and over­
weight, the significant difference between genders did not 
change considerably after adjustment for age, education, 
and smoking. The variables that were associated with 
lower odds of obesity in the logistic regression model 
were older ages, male gender, living in rural areas, lower 
level of education, and smoking. Odds ratio (OR) of being 
obese comparing females to males was 1.8 (95% CI: 1.6– 
2.0). Ethnicity, alcohol consumption, and physical activ­
ity were not significant predictors of the obesity. Similar 
results were obtained in the logistic regression model for 
overweight. OR of being overweight comparing women to 
men was 2.7 (95% CI: 2.4–3.1). The only difference was 
that alcohol consumption was associated with higher 
odds of being overweight. Linear regression model using 
BMI as the outcome showed similar results, although the 
association of alcohol consumption showed a week asso­
ciation with higher BMI (p-value: 0.095). 
Overall prevalence rates of overweight among men and 
women in rural areas were 50.1% and 64.6%, respectively, 
while these rates in urban areas were 58.4% and 73.5%, 
respectively. The prevalence rates of obesity among men 
and women living in rural areas were 14.2% and 33.6%, 
respectively, which were lower than the rates in urban 
areas, 18.9% and 38.9%, respectively. There prevalence of 
obesity and the factors associated with it were similar in 
different ethnic groups. 
High WHR was observed in 74.5% of the study popula­
tion (95% CI: 73.6%–75.4%). The prevalence rates of 
high WHR were 54.7% (95% CI: 53.1%–56.3%) among 
men and 88.9% (95% CI: 88.0%–89.7%) among women. 
Since WHR is suggested to be independent risk factor of 
cardiovascular diseases, we looked at the overlap between Page 4 of 9 
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 Table 2: Adjusted* and unadjusted prevalence rates of obesity and overweight in Golestan Cohort Study, Iran, and Third National
Health and Nutrition Examination Survey (NHANES III), United States 
Iran United States 
Unadjusted 
Adjusted 
Overweight 
Obesity 
Overweight 
Obesity 
Overall 
Men 
Women 
Overall 
Men 
Women 
Overall 
Men 
Women 
Overall 
Men 
Women 
Golestan Cohort 
Study 
63.5 (0.5)† 
54.9 (0.8) 
69.7 (0.6) 
28.4 (0.4) 
17.0 (0.6) 
36.6 (0.7) 
62.2 (0.5) 
53.7 (0.8) 
68.6 (0.6) 
28.0 (0.4) 
16.2 (0.6) 
34.9 (0.7) 
1999–2002 
65.2 (0.8) 
68.6 (0.9) 
62.0 (1.2) 
30.5 (0.9) 
27.5 (0.9) 
33.4 (1.2) 
65.1 (0.8) 
68.8 (0.9) 
61.6 (1.2) 
30.4 (0.9) 
27.5 (0.9) 
33.2 (1.2) 
1988–1994 
54.9 (0.8) 
59.4 (1.0) 
50.7 (1.0) 
22.3 (0.6) 
19.5 (0.7) 
25.0 (0.9) 
56.0 (0.8) 
61.0 (1.0) 
51.4 (1.0) 
22.9 (0.7) 
20.2 (0.7) 
25.5 (0.9) 
 *Adjustments for age have been performed in both populations to the 2000 US standard population using 5-year age groups. 
† Data presented as: percent (standard error) 
high WHR and high BMI. The overall percent agreement 
and kappa statistic between high WHR and overweight 
were 76.7% and 0.44 (standard error: 0.01), respectively. 
About 49.8% of subjects with normal weight (18.5 ≤ 
BMI<25 kg/m2) had high WHR and 9.7% of overweight 
participants had low WHR. The agreement between high 
WHR and overweight was higher in men than in women 
(kappa statistics: 0.58 and 0.27, respectively). In other 
words, women have higher chance of having high WHR 
even if they have normal weight. The other finding was 
that 77.3 % of women with normal BMI had high WHR, 
while only 4.3% of women with low WHR had high BMI. 
These proportions were 24.8% and 19.1%, respectively, 
among men. The similarity between these two propor­
tions among men brings about the rather similar preva­
lence rates of overweight and high WHR among men, 
while prevalence of high WHR is significantly higher than 
the prevalence of overweight among women. 
About 80.7% of participants had either high BMI ≥ 25 kg/ 
m2 or high WHR (95% CI: 79.8%–81.5%). This rate was 
65.2% (95% CI: 63.7%–66.7%) among men and 91.9% 
(91.1%–92.6%) among women. High waist circumfer­
ence (more than 102 cm in men and 88 cm in women) 
was observed in 58.4% of participants. 
The aforementioned analyses were repeated in a subset of 
the study population (4,408 consecutive participants who 
have been recruited in the last half of the study) for whom 
FFQ were filled and therefore data on daily calorie intake 
were available. This subset of the population consisted of 
1,731 males and 2,317 females with a mean age of 53.1 ± 
9.4 years. All these participants were recruited during sec­
ond and third years of accrual. There was no association 
between gender and daily calorie intake. In the logistic 
regression model, participants in the highest tertile of 
daily calorie intake had higher prevalence of overweight 
compared to the participants in lower two tertiles (OR: 
1.15, 95% CI: 1.00–1.33, p-value: 0.04). However, daily 
calorie intake was not a significant predictor of obesity, 
abdominal obesity (estimated by high WHR), and BMI in 
the multivariate logistic and linear regression models. 
Prevalence of hypertension and diabetes mellitus 
Unadjusted Prevalence of hypertension was 32.5% (95% 
CI: 31.6%–33.5%) and hypertension was more common 
in women than men (OR: 1.2, 95% CI: 1.1–1.4). Table 3 
compares the crude and adjusted prevalence of hyperten­
sion in our study with the results of NHANES III. While 
unadjusted prevalence rate of hypertension in Iranian and 
American women are rather similar, adjusted prevalence 
rate of hypertension in Iranian women is significantly 
higher than Americans. Mean BMI in participants with 
and without hypertension was 27.6 and 27.3 kg/m2 (p­
value: 0.08). In logistic regression model, diabetes melli­
tus and female gender were the only risk factors associated 
with hypertension. There was no significant association 
between hypertension and body weight. Page 5 of 9 
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Table 3: Adjusted* and unadjusted prevalence of hypertension in Golestan Cohort Study, Iran, and Third National Health and
Nutrition Examination Survey (NHANES III), United States 
Iran (Golestan Cohort Study) USA (NHANES III) 
Unadjusted Overall 32.5 (0.5) † 30.1 (1.0) 
Men 29.8 (0.7) 27.5 (1.2) 
Women 34.5 (0.7) 32.7 (1.1) 
Adjusted Overall 33.8 (0.5) 29.9 (0.8) 
Men 29.4 (0.7) 28.7 (1.2) 
Women 35.7 (0.7) 30.5 (0.7) 
 *Adjustments for age have been performed in both populations to the 2000 US standard population using 5-year age groups. 
† Data presented as: percent (standard error) 
Diabetes mellitus was reported in 6.1% (95% CI: 5.7%– 
6.7%) of participants. In logistic regression model, hyper­
tension and living in urban areas were only predictors of 
diagnosed diabetes mellitus. Prevalence of diabetes melli­
tus in men and women was 4.4% and 7.4%, respectively. 
In multivariable logistic regression model, odds of having 
diagnosed diabetes mellitus in women was higher than 
men (OR: 1.9; 95% CI: 1.5–2.3). Diabetic participants 
had significantly higher BMI (p-value: 0.04). 
Alcohol and smoking 
Alcohol consumption rate was 7.5% (95% CI: 7.0%– 
8.1%) and men had a significantly higher rates of alcohol 
consumption comparing to women (17.8% and 0.1%, 
respectively, p-value < 0.01). 
Current smoking rates were 33.2% (95% CI: 32.4%– 
34.0%) in men and 2.2% (95% CI: 2.0%–2.4%) in 
women. Ever smoking rates in men and women were 
47.0% and 2.6%, respectively. Adjusting for smoking in 
multivariable logistic models for obesity and overweight 
reduced the magnitude of the differences between gen­
ders. 
Discussion 
Once considered as the main public health problem of the 
developed countries, obesity has become a major prob­
lem throughout the world and the prevalence of obesity is 
increasing in most developing countries as well. 
The first important finding of our study was that the esti­
mated overall prevalence of obesity in an Iranian popula­
tion is quite comparable to the US [14] and higher than 
United Kingdom, France, Netherlands, and Italy [15-19]. 
These results are consistent with similar reports from Iran 
[20-22] as well as other countries in Middle East [23-30]. 
Even some reports from some Middle Eastern countries 
show a higher prevalence of obesity comparing to the US 
[31]. While World Health Organization (WHO) has esti­
mated that the mean BMI in Africa and Asia is about 22– 
23 Kg/m2 [32], the average BMI in our study as well as in 
other studies in Middle East is similar to the North Amer­
ican and European countries. The increasing prevalence of 
obesity has brought about the increase in myriad of public 
health consequences in these countries. Currently, cardio­
vascular diseases (47%) and cancer (14%) account for 
more than 60% of mortality in Iran [21]. 
One major concern in comparing our results with the 
results of the NHANES III was the generalizability of these 
findings to the total population in Iran. Our study was a 
large population-based study and consisted of both urban 
and rural populations. However, the study population 
consisted of individuals older than 35 years old. In order 
to address this limitation, we compared the age-specific 
rates between Iranian and American populations. Also, 
our study population had higher proportion of females 
comparing to the total population of Iran. This might 
have resulted in a slight overestimation of the prevalence 
of obesity in Iranian general population. However, even if 
we calculate the prevalence rate based on the male/female 
ratio in the total population of Iran (approximately 1:1) 
[33], the adjusted prevalence rate of overweight and obes­
ity will be 61.2% and 25.6%, respectively, which are still 
comparable to the rates in the United States. In addition, 
our results were consistent with the results of Tehran Lipid 
and Glucose Study (TLGS), another large cohort study 
that was carried out in urban population of the capital city 
of Tehran [21]. In TGLS, 63.1% of the adult population 
over 20 years old were overweight (BMI ≥ 25 kg/m2) and 
23.1% of them were obese (Table 3). This consistency in 
findings indicates a reasonable generalizability of our 
results, although generalizability is still one of the limita­
tions of this study. 
Since the standardized prevalence rates in the US popula­
tion are calculated using all age-groups, one of our con­
cerns was if the adjusted rates in US are affected by the 
lower prevalence of obesity in lower age-groups. There­
fore, we calculated the truncated age-adjusted prevalence 
of obesity and overweight in both populations (using the 
population above 35 years old). Because the age-specific Page 6 of 9 
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rates from NHANES III were available in 10-year intervals, 
these rates are calculated using 10-year age intervals and 
therefore, the results are slightly different from what 
reported above. The truncated adjusted prevalence of 
overweight in our study and in NHANES III was 53.7% 
and 66.7%, respectively, among men and 68.8% and 
57.3%, respectively, among women. Truncated adjusted 
prevalence rates of obesity in Iranian men and women 
were 16.1% and 36.2%, respectively, and these rates were 
23.2% and 28.8% in American population. 
The other important result of this study was the discrep­
ancy in gender distribution of obesity and overweight in 
Iran comparing to the US. This discrepancy was also 
observed in several other studies conducted in the Middle 
East [21,23,25,29], although some studies have shown a 
pattern close to what is observed in the United States [28]. 
As it is shown in Table 3, the results of TGLS were com­
pletely consistent with our results. In a study by Yumuk et 
al [23], the prevalence of obesity among Turkish women 
and men was 32.4% and 14.1%, respectively, while the 
prevalence of overweight among men and women was 
65.9% and 50.4%, respectively. In Saudi Arabia, the prev­
alence of obesity is estimated to be between 17–44% in 
women and 13–26% in men [25-27,34] and in Egypt, the 
prevalence of obesity ranges from 40.6% among women 
living in urban areas to 6% among men living in rural 
areas [29]. 
Therefore, although the overall prevalence of overweight 
and obesity in Iranian population–as well as many other 
Middle Eastern populations–is rather similar to the Amer­
ican population, Iranian women tend to be more obese 
than American women and Iranian men are less obese 
than their American counterparts. As explained above, 
both our study and the TLGS demonstrated a significantly 
higher prevalence of overweight and obesity among 
women. We tested several hypotheses that could poten­
tially explain this difference. One hypothesis was that 
probably these results are explained by differences in 
physical activity or calorie intake. In other words, Iranian 
women might have less physical activity and/or higher 
calorie intake comparing to Iranian men and American 
women. However, neither physical activity nor calorie 
intake were significantly different between Iranian men 
and women. Lack of association between gender and 
physical activity or calorie intake reduces the probability 
that the gender discrepancy in prevalence of obesity is due 
to these factors. Since physical activity was estimated 
using a different questionnaire, the direct comparison 
between our results and the results of studies conducted in 
developed countries was not possible. Although the total 
calorie intake was not associated with gender and there­
fore has low probability of being a confounder, it is possi­
ble that differences in the dietary contents–rather than 
total calorie intake–account for part of the discrepancy 
between Iranian men and women as well as the discrep­
ancy between Iranian people and their American counter­
parts. Another hypothesis is the constitutional and 
biological differences between two populations or resid­
ual confounding due to the factors that we have not meas­
ured in this study. 
The strongest hypothesis that was supported by this study 
is the difference in smoking habits. Smoking is shown to 
be associated with lower BMI and even some authors have 
suggested that decreasing rates of smoking in the US is 
one of the important contributing factors to the rising 
prevalence of obesity in the US [35]. Current smoking 
rates among men and women in our study were 33.2% 
and 2.2%, respectively, while these rates among American 
men and women are 24.8% and 20.1%, respectively. 
Therefore differences in smoking rates is consistent with 
discrepancy between Iranian men and women as well as 
the discrepancy between Iranian and American popula­
tion. 
Other important results of our study were the prevalence 
rates of hypertension and diabetes mellitus as two other 
risk factor of cardiovascular diseases and two other criteria 
of metabolic syndrome. Prevalence of hypertension in our 
study was quite comparable with prevalence rates in the 
US. Diabetes mellitus was measured based on self-report 
and since a significant proportion of diabetic cases are not 
clinical, our results significantly underestimates the prev­
alence of diabetes. Consequently, the interpretation of 
our findings should be limited to the diagnosed cases of 
diabetes. Prevalence of diabetes in this Iranian population 
was slightly lower than the US population–with about 8% 
prevalence of diabetes–and is higher than what is reported 
in some neighboring countries, e.g. 3.4% in Turkey [23]. 
Other studies have shown that Iranian people have high 
rates of high HDL-cholesterol as another criterion of met­
abolic syndrome. Azizi et al, have shown that in TLGS, 
73% of participants had low HDL-cholesterol, which is 
more than what had been previously reported in many 
western countries [22]. 
The other finding that requires further elaboration is the 
high prevalence of abdominal obesity in Iranian women. 
While mean WHR in 19 populations studied in WHO 
MONICA project [36] was from 0.87–0.99 in men and 
from 0.76–0.84 in women, the mean WHR among men 
and women in our study was 0.96 in both men and 
women. The median WHR in Iranian women was 0.95, 
while the median WHR in a Danish population was 0.80 
[37]. Therefore, Iranian women have considerably higher 
WHR comparing to other countries and as mentioned 
above, a large proportion of women in our study popula­
tion had high WHR even with normal BMI. This might be Page 7 of 9 
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Table 4: Age-adjusted prevalence of obesity and overweight in Golestan Cohort Study (North-East of Iran) and Tehran Lipid and 
Glucose Study. [21] (Tehran, Iran) 
Golestan Cohort Study Tehran Lipid and Glucose Study 
Overweight (%) Overall 
Men 
Women 
62.2 
53.7 
68.6 
63.1 
57.0 
67.6 
Obesity (%) Overall 
Men 
Women 
28.0 
16.2 
34.9 
23.1 
14.4 
29.5 
due to genetic predisposition of Iranian women, lower 
smoking rates, or differences in epigenetic programming 
of Iranian women. 
Prevalence of obesity and metabolic syndrome is increas­
ing in Iran. TLGS showed the trend in rising prevalence of 
obesity and overweight in Tehran [38]. Considering the 
constant increase in prevalence of obesity in both US and 
Iran, Table 2 provides a rough estimate of where our 
results fall within the trend of obesity in the US. Techno­
logical changes that has lowered both the real cost of food 
and the level of physical activity [39], increased food con­
sumption [40], and decrease in smoking rate [35] are 
among the reasons suggested for this trend. Also, as men­
tioned above, the transition toward a Western lifestyle has 
put a population that is susceptible to obesity–due to fac­
tors like epigenetic programming–at high risk of obesity, 
metabolic syndrome, and their consequences. The fact 
that women in our study, comparing to American women, 
showed significantly higher prevalence rates in lower age 
groups is consistent with the latter hypothesis, as older 
women have had been less affected by consequences of 
industrialization. 
Conclusion 
Prevalence of obesity and overweight in Iran-as well as 
other Middle Eastern countries–is as high as the United 
States. However, Iranian women are more obese than 
American women, while Iranian men are less obese than 
their American counterparts. This discrepancy might be 
due to the low rate of smoking among Iranian women 
comparing to both Iranian men and American women. 
Demonstration of this association requires further investi­
gation. Iranian women tend to have higher WHR compar­
ing to many other populations. Further studies are 
necessary to elucidate the reasons for this finding as well 
as the necessity of changing the definition of abdominal 
obesity in Iran based on the distribution of WHR in Ira­
nian population. Prevalence of hypertension and diabetes 
mellitus in our study was similar to the US population. 
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